[Association of hyperinsulinemia with left ventricular hypertrophy and diastolic dysfunction in patients with

Ernesto Germán Cardona-Muñoz1, David Cardona-Müller, Sylvia Totsuka-Sutto

  • 1Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, México. came_1@lycos.com

Revista Medica De Chile
|December 8, 2007
PubMed

Insights

Hyperinsulinemia, characterized by high insulin levels, is linked to increased ventricular mass and diastolic dysfunction in hypertensive patients. This association persists regardless of blood pressure or age, highlighting insulin

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Hypertension Research

Context:

  • Hypertension is a primary independent risk factor for cardiovascular disease.
  • Additional factors beyond blood pressure contribute to organ damage in hypertensive individuals.
  • Hyperinsulinemia, characterized by elevated insulin levels, is increasingly recognized as a potential contributor to cardiovascular complications.

Purpose:

  • To investigate the relationship between hyperinsulinemia and cardiac structural and functional changes.
  • To assess the association between elevated insulin levels, left ventricular hypertrophy, and diastolic dysfunction in patients with hypertension.

Summary:

  • A study involving 74 hypertensive patients (aged 30-65) with normal glucose tolerance evaluated associations between insulin levels and cardiac parameters.
  • Patients were categorized into normoinsulinemic, post-prandial hyperinsulinemic, and persistently hyperinsulinemic groups based on fasting and post-glucose challenge insulin levels.
  • Results indicated a negative correlation between ventricular mass and insulin levels (rG/I), with significantly worse left ventricular diastolic dysfunction observed in persistently hyperinsulinemic individuals.

Impact:

  • Fasting and post-challenge hyperinsulinemia, particularly with an insulin resistance index (rG/I) below 1, are independently associated with increased left ventricular mass and diastolic dysfunction.
  • These findings suggest that hyperinsulinemia is a significant factor contributing to cardiac damage in hypertension, independent of blood pressure and age.
  • The study underscores the importance of considering metabolic factors like hyperinsulinemia in the comprehensive management of hypertensive cardiovascular risk.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...